Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol in Cirrhosis
NCT05545670Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Cirrhosis comparing Placebo with Allopurinol (2 arms). Primary endpoint: Morbidities at 6 months. Started Jun 2022; status: completed.
02
Drugs
allopurinol
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on NCT05545670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05545670.